Overweight (BMI > 25), Obesity
Conditions
Keywords
diabetes screening
Brief summary
Approximately 130 million Americans have prediabetes or type 2 diabetes (T2D) but remain unscreened and/or unaware of their diagnosis. While prediabetes/T2D screening, also known as glycemic screening, is endorsed in national guidelines, there is almost no research on how to increase screening rates, or evaluations of interventions testing the effectiveness of screening promotion strategies. The American Medical Association has published prediabetes quality measures that apply to UCLA Health as well as all other health systems, specifically tracking the percentage of adult patients with risk factors for T2D due for glycemic screening for whom the screening process was initiated. However, there is no current systemic effort underway at UCLA, or most other health systems, to encourage glycemic screening. We are proposing a pilot trial of the first SMART (Sequential Multiple Assignment Randomized Trial) for glycemic screening. Our SMART experiment will provide preliminary feasibility and acceptability data for a larger, multisite trial that will provide vital guidance to optimize screening approaches for a growing number of screening-eligible patients so that they may seek earlier detection, treatment, and/or access to lifestyle programs and interventions for T2D or prediabetes.
Interventions
BEHAVIORALText message
Participants receive a text message encouraging glycemic screening
BEHAVIORALPatient portal message
Participants receive a patient portal message encouraging glycemic screening
BEHAVIORALMailed letter
Participants receive a mailed letter encouraging glycemic screening
Sponsors
University of California, Los Angeles
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Overweight or obese
Exclusion criteria
* Existing type 2 diabetes, A1c drawn within past 3 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hemoglobin A1c | 90 days | Receipt of hemoglobin A1c screening for dysglycemia |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Acceptability survey | 90 days | Participants will receive a Qualtrics survey with the following 5 items: 1. How did you feel about the messages recommending that you come in for a blood test to check your hemoglobin A1c (blood sugar) level? 2. How clear were the messages recommending that you come in for a blood test to check your hemoglobin A1c (blood sugar) level? 3. Did the messages affect the chances that you would get the hemoglobin A1c (blood sugar) level? 4. Did the messages cause you any anxiety or stress? 5. How concerned were you that the messages were from scammers not associated with UCLA? |
Countries
United States
Outcome results
None listed